Life Summary
Oh Won-il is the CEO of Medipost.

He is working to expand into the global market with "Cartistem," a knee osteoarthritis treatment.

He was born on October 2, 1962.

He graduated from Seoul National University College of Medicine and earned his master's and doctoral degrees in medicine from Seoul National University Graduate School.

After serving as a clinical instructor at Ulsan University College of Medicine's Asan Medical Center in Seoul, he worked as an assistant professor at Sungkyunkwan University School of Medicine's Samsung Medical Center.

He joined Medipost in 2004 and held positions as Head of R&D and Vice President before being appointed CEO in 2022.

He is expanding the market with the stem cell therapy "Cartistem" and the proprietary "SMUP-Cell" technology platform.

#OhWonil #Medipost #Cartistem #stemcell #biotechnology #medicalresearch #healthcare #SamsungMedicalCenter #SeoulNationalUniversity #biopharma